|
(PQA3) Why is Ovarian Cancer Primarily a Disease of Postmenopausal Women
|
5R21CA194626-02
|
$190,313
|
ORSULIC, SANDRA
|
CEDARS-SINAI MEDICAL CENTER
|
|
(PQD2)New Biomarkers and Pathways to Enhance Cure in Ovarian Cancers
|
5R01CA184968-03
|
$509,161
|
SIKIC, BRANIMIR
|
STANFORD UNIVERSITY
|
|
(PQD5) Avatar-directed Treatment for Ovarian Cancer
|
5R01CA184502-03
|
$714,297
|
WEROHA, SARAVUT
|
MAYO CLINIC ROCHESTER
|
|
4C and Genome Editing for Causal SNP and Gene Discovery at Cancer Risk Loci
|
5R21CA191725-02
|
$185,077
|
FREEDMAN, MATTHEW
|
DANA-FARBER CANCER INST
|
|
A Multimodal Imaging Strategy for Preclinical Optimization of Anticancer Nanomedicines
|
1F31CA203476-01
|
$34,274
|
RADFORD, DAVID
|
UNIVERSITY OF UTAH
|
|
A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer
|
5R01CA175318-02
|
$354,563
|
HATEFI, ARASH
|
RUTGERS, THE STATE UNIV OF N.J.
|
|
A network platform to connect drug response and prognosis phenotypes for cancers
|
1R01CA196631-01A1
|
$395,911
|
LI, HU
|
MAYO CLINIC ROCHESTER
|
|
A Pathway-based approach to investigate oncogenic mechanisms in ovarian cancer
|
5R00CA166228-04
|
$249,000
|
GATZA, MICHAEL
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
A Phase I Dose-escalation Study of Intraperitoneal CYN101 as Consolidation Immunotherapy in Women with Residual or Recurrent Ovarian Cancer Status after Chemotherapy
|
1R44CA206606-01
|
$995,814
|
WILDS, DAN
|
CYNVEC, LLC
|
|
A Universal Approach to Personalized Adoptive T cell Therapy of Cancer
|
4R01CA168900-05
|
$332,000
|
POWELL, DANIEL
|
UNIVERSITY OF PENNSYLVANIA
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,229,987
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
2P30CA016520-40
|
$7,975,543
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S1
|
$31,250
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S2
|
$499,967
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S3
|
$200,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Activatable molecular cancer imaging probe
|
ZIA BC 011512
|
$304,350
|
Kobayashi, Hisataka
|
CCR (NCI)
|
|
Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research
|
4U24CA180921-04
|
$634,033
|
JACOBSON, REBECCA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Algorithms for Literature-Guided Multi-Platform Identification of Cancer Subtypes
|
1R21CA209848-01
|
$195,098
|
CHUNG, DONGJUN
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
An Epigenetic Strategy for Restoring Carboplatin Sensitivity in Ovarian Cancer
|
7R01CA182832-03
|
$323,701
|
MATEI, DANIELA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Analysis of BRCA1 Recombination Functions
|
5R01CA095175-12
|
$328,700
|
SCULLY, RALPH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells
|
5R01CA181543-03
|
$396,541
|
BRUGGE, JOAN
|
HARVARD MEDICAL SCHOOL
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,014,935
|
Barr, Frederic
|
CCR (NCI)
|
|
Annotating the Role of Dysregulated Inositol Phosphate Metabolism in Malignant Ca
|
4R01CA172667-04
|
$334,803
|
NOMURA, DANIEL
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AID
|
ZIA SC 004020
|
$2,321,426
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Applying the Cloud Computing resources to efficiently and comprehensively accomplish genomic analysis of TCGA/ICGC samples
|
3R01CA172652-03S1
|
$64,000
|
CHEN, KEN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer
|
5R01CA135354-06
|
$380,000
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Ashwagandha supplementation enhances ovarian tumoricidal activity of NK cells
|
5R21CA187309-02
|
$171,399
|
BARUA, ANIMESH
|
RUSH UNIVERSITY MEDICAL CENTER
|
|
Assistant Director Flow and Image Cytometry Roswell Park Cancer Institute
|
1R50CA211108-01
|
$250,131
|
MINDERMAN, HANS
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
B7-H1 Signaling in Ovarian Cancer
|
4R01CA164122-05
|
$310,213
|
CURIEL, TYLER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
BASE PERIOD PERIOD OF PERFORMANCE: 3/1/2016 - 2/28/2017 DESCRIPTION: CENTRAL DATA COLLECTION CENTER (CDCC)
|
261201600007I
|
$2,132,987
|
UNKNOWN, UNKNOWN
|
WESTAT INCORPORATED
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,732,997
|
Custer, Mary
|
CCR (NCI)
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S1
|
$118,016
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S2
|
$170,897
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S3
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S4
|
$499,947
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S5
|
$134,220
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-10
|
$3,253,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
BCDDP: Breast cancer detection demonstration project followup study - I
|
ZIA CP010182-01030
|
$46,268
|
Schairer, Catherine
|
DCEG (NCI)
|
|
Behavioral Influences on Ovarian Cancer Progression: Role of Chemoresistance
|
1R01CA193249-01A1
|
$668,888
|
LUTGENDORF, SUSAN
|
UNIVERSITY OF IOWA
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$791,464
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Blocking NK cell shedding of CD16a to increase cancer cell killing
|
1R01CA203348-01
|
$443,533
|
WALCHECK, BRUCE
|
UNIVERSITY OF MINNESOTA
|
|
Bmi-1, a potential therapeutic target in ovarian cancer
|
7R01CA157481-05
|
$311,480
|
BHATTACHARYA, RESHAM
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
BRCA1 Function in Post-Damage Nuclear Foci
|
2R01CA136512-06A1
|
$515,452
|
LIVINGSTON, DAVID
|
DANA-FARBER CANCER INST
|
|
Breast imaging studies in women at high genetic risk of breast cancer
|
ZIA CP010145-07040
|
$31,798
|
Loud, Jennifer
|
DCEG (NCI)
|
|
Breast, Colorectal, and Ovary Cancer Clinical Validation Center
|
2U01CA152637-06
|
$1,011,430
|
LI, CHRISTOPHER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,579,134
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Building upon a tradition of excellence. The NCTN at Indiana University
|
5U10CA180795-03
|
$611,729
|
MILLER, KATHY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Cancer Center Support (CORE) Grant
|
3P30CA034196-31S1
|
$458,945
|
LIU, EDISON
|
JACKSON LABORATORY
|
|
Cancer Center Support (CORE) Grant
|
5P30CA034196-31
|
$2,100,000
|
LIU, EDISON
|
JACKSON LABORATORY
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-41S1
|
$120,000
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|